LivaNova price to book ratio LIVN

Market value divided by the book value of the company's net assets, since 2015.

Today, Oct 23, 2026: 3.4×
10-year median: 2.4×
Against its 10-year history: 89th; percentile: 0 is its lowest day, 100 its highest
10-year range: 1.1× to 4.1×
Peer median: 2.7×

LivaNova's price to book ratio is 3.4× as of Oct 23, 2026.

That is above its ten-year median of 2.4×, higher than on 89% of days in the last ten years.

Over that time it ranged from 1.1× in Nov 2016 to 4.1× in Jul 2021.

The median for 6 medical device stocks of a similar size is 2.7×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.4×	2.7×	3.8×
2025	3.0×	1.4×	3.0×
2024	1.9×	1.9×	2.8×
2023	2.3×	1.8×	2.7×
2022	2.6×	1.8×	3.5×
2021	3.5×	2.3×	4.1×
2020	2.4×	1.3×	2.5×
2019	2.4×	2.2×	3.1×
2018	2.4×	2.0×	3.4×
2017	2.0×	1.2×	2.2×
2016	1.2×	1.1×	10.4×
2015	10.4×	9.5×	10.9×

Against its peers

Companies in Medical - Devices nearest LivaNova's size, closest first, today.

Company	Price to book ratio
LIVNLivaNova	3.4×
ITGRInteger	2.5×
TMDXTransMedics	4.7×
CNMDCONMED	1.4×
ZBHZimmer Biomet	1.5×
DXCMDexCom	11.2×
GEHCGE HealthCare Technologies	2.9×
Peer median	2.7×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on LivaNova

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.